United Therapeutics Stock Soars on Strong Phase 3 Lung Disease Results [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
United Therapeutics ( NASDAQ:UTHR ) surged 14% on Monday after the company reported positive Phase 3 results for nebulized Tyvaso in treating idiopathic pulmonary fibrosis, a chronic lung disease that causes scarring and makes breathing difficult, according to a company announcement. The TETON-1 and TETON-2 studies showed the inhaled therapy achieved a statistically significant improvement in forced vital capacity, a key measure of lung function, compared with placebo. Integrated data also demonstrated a reduction in the risk of clinical worsening across patient subgroups, with a safety profile consistent with previous trials. Warning! GuruFocus has detected 6 Warning Sign with UTHR. Is UTHR fairly valued? Test your thesis with our free DCF calculator. The results reinforce consistent efficacy across multiple endpoints, supporting the potential for an expanded indication. Idiopathic pulmonary fibrosis affects about 100,000 people in the U.S., and current treatment options are
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.MarketBeat
- United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $486.00 to $575.00. They now have an "equal weight" rating on the stock.MarketBeat
- United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo [Yahoo! Finance]Yahoo! Finance
- United Therapeutics (UTHR) had its price target raised by Bank of America Corporation from $569.00 to $626.00. They now have a "neutral" rating on the stock.MarketBeat
- Why United Therapeutics (UTHR) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form 4
- 3/31/26 - Form 4
- UTHR's page on the SEC website